Curious about Nordson (NDSN) Q2 Performance? Explore Wall Street Estimates for Key Metrics

23.05.25 15:15 Uhr

Werte in diesem Artikel
Aktien

171,45 EUR -0,85 EUR -0,49%

76,50 EUR 0,00 EUR 0,00%

Indizes

18.737,2 PKT -188,5 PKT -1,00%

Wall Street analysts expect Nordson (NDSN) to post quarterly earnings of $2.36 per share in its upcoming report, which indicates a year-over-year increase of 0.9%. Revenues are expected to be $673.58 million, up 3.5% from the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.Bearing this in mind, let's now explore the average estimates of specific Nordson metrics that are commonly monitored and projected by Wall Street analysts.Analysts expect 'Net Sales- Industrial Precision Solutions' to come in at $322.96 million. The estimate suggests a change of -12% year over year.According to the collective judgment of analysts, 'Net Sales- Advanced Technology Solutions' should come in at $142.32 million. The estimate indicates a change of +24.1% from the prior-year quarter.The consensus among analysts is that 'Net Sales- Medical and Fluid Solutions' will reach $204.99 million. The estimate indicates a change of +21.3% from the prior-year quarter.The consensus estimate for 'Operating profit (loss)- Advanced Technology Solutions' stands at $27.56 million. The estimate compares to the year-ago value of $18.78 million.The combined assessment of analysts suggests that 'Operating profit (loss)- Medical and Fluid Solutions' will likely reach $55.41 million. Compared to the present estimate, the company reported $48.99 million in the same quarter last year.The average prediction of analysts places 'Operating profit (loss)- Industrial Precision Solutions' at $108.47 million. Compared to the current estimate, the company reported $117.83 million in the same quarter of the previous year.View all Key Company Metrics for Nordson here>>>Nordson shares have witnessed a change of +3.4% in the past month, in contrast to the Zacks S&P 500 composite's +10.7% move. With a Zacks Rank #3 (Hold), NDSN is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.0% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Nordson Corporation (NDSN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Nordson und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Nordson

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Nordson

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Nordson Corp.

Wer­bung

Analysen zu Nordson Corp.

DatumRatingAnalyst
08.01.2019Nordson OutperformOppenheimer & Co. Inc.
09.01.2018Nordson Mkt PerformBarrington Research
15.12.2017Nordson HoldGabelli & Co
23.08.2017Nordson BuyGabelli & Co
22.02.2017Nordson OutperformBarrington Research
DatumRatingAnalyst
08.01.2019Nordson OutperformOppenheimer & Co. Inc.
23.08.2017Nordson BuyGabelli & Co
22.02.2017Nordson OutperformBarrington Research
16.12.2016Nordson OutperformBarrington Research
10.06.2016Nordson BuyGabelli & Co
DatumRatingAnalyst
09.01.2018Nordson Mkt PerformBarrington Research
15.12.2017Nordson HoldGabelli & Co
25.05.2016Nordson Sector PerformRBC Capital Markets
24.02.2016Nordson Sector PerformRBC Capital Markets
14.12.2015Nordson Sector PerformRBC Capital Markets
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Nordson Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen